JohnHBartonMD

PubMed

• TRIPS and the Global Pharmaceutical Market
  John Barton, MD> ;Health Affairs. 2004 May 27
• A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.
  Burris, H. A.,Infante, J. R.,Anthony Greco, F.,Thompson, D. S.,Barton, J. H.,Bendell, J. C.,Nambu, Y.,Watanabe, N.,Jones, S. F.> ;Cancer Chemother. Pharmacol.. 1900 Jan 01
• A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory m...
  Bendell, J. C.,Jones, S. F.,Hart, L.,Spigel, D. R.,Lane, C. M.,Earwood, C.,Infante, J. R.,Barton, J.,Burris, H. A.> ;Invest New Drugs. 2014 Oct 23
• Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology...
  Yardley DA, Burris HA, Clark BL, Shipley D, Rubin M, Barton J, Arrowsmith E, Hainsworth JD> ;Clin. Breast Cancer. 2011-06-01
• Amrubicin as second- or third-line treatment for patients with HER2-negative metastatic breast cancer (MBC): A Sarah Cannon Research Institute phase I trial.
  Barton JH, Shih KC, Raefsky E, Haines DW, Strike B, Hainsworth JD, Burris HA, Yardley DA> ;J. Clin. Oncol.. 2011-05-20
• Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer.
  Spigel DR, Hainsworth JD, Barton JH, Patton JF, Zubkus JD, Simons L, Griner P, Burris HA, Greco FA> ;J Thorac Oncol. 2010-06-01
• Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology ...
  Hainsworth JD, Spigel DR, Burris HA, Shipley D, Farley C, Macias-Perez IM, Barton J, Greco FA> ;Cancer. 2010-05-15
• Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer.
  Burris HA, Jones SF, Shipley D, Meluch AA, Greco FA, Barton JH, Yardley DA, Hainsworth JD> ;Cancer Invest.. 2010-05-01
• A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancer.
  Yardley DA, Burris HA, Spigel DR, Clark BL, Vazquez E, Shipley D, Barton J, Thompson D, Montes I, Greco FA, Hainsworth JD> ;Clin. Breast Cancer. 2009-11-01
• Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.
  Yardley DA, Burris HA, Hanson S, Greco FA, Spigel DR, Barton J, Hainsworth JD> ;Clin. Breast Cancer. 2009-08-01
• Phase I dose escalation study of pomalidomide in combination with gemcitabine in patients (pts) with untreated metastatic carcinoma of the pancreas.
  Infante JR, Jones SF, Bendell J, Spigel D, Barton J, Zubkus J, Byrne C, Griner P, Weekes C, Messersmith WA, Burris HA> ;J. Clin. Oncol.. 2009-05-20
• Efficacy results from a multicenter phase II noncomparative two-arm pilot trial of bevacizumab with anastrozole or fulvestrant as first-line endocrine therapy for meta...
  Rubin MS, Barton J, Shipley D, Arrowsmith E, Peacock N, Hart L, Evans J, Vasquez E, Burris HA, Yardley DA> ;J. Clin. Oncol.. 2009-05-20
• A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.
  Yardley DA, Burris HA, Simons L, Spigel DR, Greco FA, Barton JH, Shipley D, Drosick D, Hainsworth JD> ;Clin. Breast Cancer. 2008-10-01
• A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high...
  Yardley DA, Burris HA, Farley CP, Barton JH, Peacock NW, Spigel DR, Greco FA, Hainsworth JD> ;Clin. Breast Cancer. 2008-06-01
• A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors.
  Doss HH, Jones SF, Infante JR, Spigel DR, Willcutt N, Lamar R, Barton J, Keegan M, Burris HA> ;J. Clin. Oncol.. 2008-05-20
• A randomized phase II trial of oral topotecan versus docetaxel in the second-line treatment of non-small-cell lung cancer.
  Jones S, Thompson D, Barton J, Patton J, Shipley D, Greco FA, Spigel D, Infante J, Burris HA> ;Clin Lung Cancer. 2008-05-01
• A phase II trial of biweekly pemetrexed (P) and gemcitabine (G) in the first-line treatment (tx) of patients (pts) with advanced non-small cell lung cancer (NSCLC).
  Peacock NW, Spigel DR, Hainsworth JD, Yardley DA, Burris HA, Barton JH, Patton JF, Shipley DL, Simons L, Greco FA> ;J. Clin. Oncol.. 2006-06-20
• Day 1 pegfilgrastim with dose dense adjuvant chemotherapy: Amelioration of docetaxel neutropenia but not that of doxorubicin/cyclophosphamide. Results from a Sarah Can...
  Yardley DA, Greco FA, Burris HA, Peacock NW, White M, Raefsky E, Thompson DS, Barton JH, Spigel DR, Hainsworth JD> ;J. Clin. Oncol.. 2005-06-01
• Phase II trial of gemcitabine plus trastuzumab in minimally pretreated HER2 overexpressing metastatic breast cancer.
  Peacock NW, Bearden J, Schnell F, White M, Greco FA, Burris HA, Barton JH, Hainsworth JD, Spigel DR, Yardley DA> ;J. Clin. Oncol.. 2005-06-01
• Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
  Greco FA, Gray JR, Thompson DS, Burris HA, Erland JB, Barton JH, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD> ;Cancer. 2002-09-15
• Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.
  Greco FA, Burris HA, Litchy S, Barton JH, Bradof JE, Richards P, Scullin DC, Erland JB, Morrissey LH, Hainsworth JD> ;J. Clin. Oncol.. 2002-03-15
• A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies.
  Jones SF, Greco FA, Hainsworth JD, Patton JW, Barton JH, Willcutt NT, Baker MN, McGuirt PV, Levin J, Burris HA> ;Oncologist. 2002-01-01
• Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial.
  Hainsworth JD, Burris HA, Litchy S, Morrissey LH, Barton JH, Bradof JE, Greco FA> ;Cancer. 2000-07-15
• Join now to see all